Yi Zhang
Meng Zhang- Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, China
Pharmacological studies have shown that some traditional Chinese medicines (TCMs) have applications in the treatment of Alzheimer’s disease (AD). Morinda officinalis How. (MO) is a TCM with a long history and is widely used to tonify kidney Yang. In vitro and in vivo experiments have suggested that MO contains various effective pharmaceutical components and chemicals, including oligosaccharides, anthraquinones, iridoids, flavonoids, amino acids, and trace elements, conferring MO with anti-inflammatory and antioxidant properties. Neuroinflammation and oxidative stress are undoubtedly hallmarks of neurodegeneration, contributing to AD progression. In this mini-review, we summarize the molecular mechanisms, structure-activity relationships, and potential synergistic and antagonistic effects of active components in MO. This discussion highlights the roles of these active components, such as oligosaccharides, anthraquinones, and iridoid glycosides, in the treatment of AD via anti-inflammatory and antioxidant mechanisms, providing a scientific basis for further utilization of MO.
Introduction
Morinda officinalis How. (MO) is a perennial vine of the genus Rubidium coba and is one of the “Four Major Southern Medicines” in China, together with areca nuts and Alopecia solanum. MO is mainly distributed in Fujian, Guangdong, Guangxi, and Hainan provinces in China (Yoshikawa et al., 1995; Wang et al., 2002). The main medicinal part of MO is its root, which is flat-cylindrical with a grayish-yellow surface and a bitter taste (Zhang et al., 2018). As a traditional Chinese medicine (TCM), MO belongs to the kidney and liver meridian and functions by tonifying kidney Yang, strengthening tendons and bones, and dispelling wind and dampness (Zhang et al., 2018). The “Shen Nong Ben Cao Jing” records state that, “MO can strengthen the body and bones, adjust the five-organ physiological function and enhance the immunity of the body.” Furthermore, as a TCM, MO warms the uterus, delays aging, and has antidepressant and antitumor effects.
The main components of MO include oligosaccharides, anthraquinones, iridoid glycosides, organic acids, trace elements, amino acids, and sterols (Zhang et al., 2022). Previous studies have suggested that oligosaccharides in MO can improve immunity, promote angiogenesis, enhance reproduction, and exert anti-osteoporosis, antioxidative, antidepressant, and antidementia effects (Xu et al., 2017; Jiang et al., 2018; Chi et al., 2020; Zhu et al., 2019). The iridoids in MO have antioxidant, anti-chromosomal mutagenesis, antitumor, anti-inflammatory, and analgesic functions (Choi et al., 2005; Zhang et al., 2020; Cai et al., 2021). Furthermore, palmitic acid and succinic acid present in MO have antidepressant effects (Cui et al., 1995; Zhu et al., 2020). Recent in vivo and in vitro experiments have confirmed that the bioactive components of MO easily cross the blood-brain barrier and play beneficial neuroactive roles in various aging and neurodegenerative disease models, including Alzheimer’s disease (AD) (Chen et al., 2017). This pharmacological mechanism of AD treatment may be realized through the anti-inflammatory and antioxidant mechanisms of MO active components (Wu Z. Q. et al., 2015; Luo et al., 2021). In the occurrence and development of AD, the overactivation of microglia and astrocyte, infiltration of T lymphocytes in brain tissue, peripheral macrophage entering brain tissue, decrease of normal phagocytosis function, increase of production and release of inflammatory cytokines, all of which can result in the aggravate of neuroinflammation and decrease of Aβ clearance (Hao Y. et al., 2020). Oxidative stress is another early change in patients with AD and leads to the production of reactive oxygen species (ROS) and free radicals, which are toxic to nerve cells (Chen and Zhong, 2014). ROS, as the main effector molecules in the process of oxidative stress, can lead to protein and lipid peroxidation, inhibit the activity of antioxidant enzymes, affect mitochondrial function, activate caspase-3, and induce neuron apoptosis through ASK1-JNK/p38 signal pathway, and involved in the pathogenesis of AD (Wu et al., 2020).
In this mini-review, we summarize the potential applications of MO in the treatment of AD and in anti-aging strategies via inhibition of neuroinflammation and antioxidant injury, aiming to provide a scientific basis for clinical use of MO in the treatment of neurodegenerative diseases.
Botany and geographical distribution of Morinda officinalis How.
MO belongs to the family Rubiaceae, and there are approximately 102 species of Morinda worldwide, which are distributed in tropical, subtropical, and temperate regions, including China. Species of Morinda differ according to geographical location, and the medicinal parts of the plant also differ; the roots, leaves and fruits of MO all have medicinal properties (Wu Y. et al., 2015; Singh and Sharma, 2020). However, the main medicinal part is the roots (Choi et al., 2005). MO roots are mostly flat and cylindrical, are slightly curved, vary in length, and show a diameter of 0.5–2 cm. The surface of the root is a gray-yellow or dark gray, with longitudinal lines and transverse cracks, and some of the bark is broken off from the exposed wood (Yao et al., 2004; Huang et al., 2016). The texture of the root is tough, and the skin section is thick with a purple or lavender color. In 2014, researchers conducted field investigations on the plant resources of MO in Fujian, Hainan, Guangdong, and Guangxi and found that there were significant differences in the leaves and roots of MO from different habitats. Leaves of MO from Fujian are leathery and protuberant (Zhang et al., 2016), and plants can be divided into two categories based on the average leaf length. Some varieties of MO grow in clusters. The root flesh is compacted, and the shape varies. In Hainan MO, the leaves are leathery and smooth, and the root flesh is compacted and shows a rosary shape. By contrast, leaves of MO from Guangdong are leathery and protuberant, and the roots are fleshy and without obvious shape. The leaves of MO from Guangxi are leathery and smooth.
Major phytochemical constituents in Morinda officinalis How.
MO contains carbohydrates, anthraquinones, iridoids, flavonoids, amino acids, and trace elements. Polysaccharides, one of the main active components of MO, have obvious biological activities, including antioxidant, antifatigue, immunoregulatory, and anti-osteoporosis effects, and may have diverse clinical applications (Zhang et al., 2018).
So far, a number of studies have reported that total or crude polysaccharides extracted from MO root have various biological activities, including the protective effect on bone loss (Liu et al., 2020), antioxidant (Zhang et al., 2013), anti-fatigue (Zhang et al., 2009) and immunomodulation (Choi et al., 2005), which suggests the polysaccharides of MO root exert important roles in its pharmacological properties (Zhang et al., 2009, 2013). Importantly, MO polysaccharides can scavenge free radicals and exert antioxidant effects (Soon and Tan, 2002). Three representative polysaccharides in MO, i.e., MP-1, MP-2, and MP-3, were found to have antifatigue activity in a weight-loaded swimming model in mice. The MP-1 were mainly identified as 1, 5-anhydro-2, 3, 4, 6-tetra-O-methyl-d-glucitol and 2, 5-anhydro-1, 3, 4, 6-tetra-O-methyl-d-mannitol; MP-2 consisted of arabinose, galacturonic acid, and galactose as the main constituents; MP-3 was an acidic polysaccharide with sulfur and nitrogen, and was rich in arabinose, as well as galacturonic acid and galactose (Figure 1; Zhang et al., 2009). In addition, MO-derived polysaccharides significantly inhibit the infiltration of neutrophils and macrophages into the liver, thereby acting as an immune regulator and alleviating hepatic injury (Xu et al., 2019). Inulin-type oligosaccharides extracted from MO (OMOs) can suppress behavioral changes in rats subjected to a single prolonged stress and cause an increase in the contents of all progesterone in the prefrontal cortex, hippocampus, and amygdala, suggesting that inulin-type oligosaccharides may have significant effects on alleviating symptoms of post-traumatic stress disorder (Qiu et al., 2016).
Figure 1. The structures of the main polysaccharides (MP-1, MP-2, MP-3) in Morinda officinalis How.
Iridoids are abundant and widely distributed in MO and are one of the main active components in MO (Hao Q. et al., 2020). Iridoids are mainly isolated from the roots, branches, leaves, and fruits of MO, and more than 50 iridoids have been isolated from MO to date (Cai et al., 2021; Figure 2). These MO-derived iridoids have various biological activities, including anti-inflammatory effects, blood flow enhancement, and antitumor effects. For example, in RAW264.7 macrophages, monotropein can inhibit lipopolysaccharide-dependent induction of tumor necrosis factor (TNF-α) and interleukin-1β (IL-1β) mRNA expression and reduce the activity of nuclear factor (NF)-κB (Shin et al., 2013). Furthermore, asperulosidic acid blocks polycoagulamine-induced erythrocyte aggregation and thrombin activity (Murata et al., 2014), suggesting that asperulosidic acid may have clinical applications in improving blood fluidity and could represent a novel therapeutic strategy for the prevention and treatment of thrombotic diseases. In terms of antitumor effects, citrifolinoside and citrifolinin A significantly inhibit the activity of ultraviolet-induced active protein 1, which plays an important role in tumor induction and growth (Sang et al., 2001; Tao et al., 2016).
Figure 2. The structures of the main iridoids in Morinda officinalis How.
Despite these findings, the effects of MO-derived compounds on the intestinal flora (Hu et al., 2016) and the potential therapeutic effects of these compounds in patients with AD have not been fully elucidated. Further studies are needed to explore the pharmacological activities of MO-derived compounds and elucidate the detailed mechanisms to provide a theoretical basis for the development of new drugs.
Traditional Chinese medicines prescriptions containing Morinda officinalis How.
TCM prescriptions are usually composed of a variety of herbs in a certain proportion, and these herbs exert synergistic roles in the whole prescription, which is the basis for the TCM prescriptions to treat diseases through multi-target and multi-mechanism (Zhao et al., 2022). Several TCM prescriptions containing MO as the main ingredient have been shown to have anti-aging effects and efficacy against AD. Er-xian and Xiao-yao formulas contain primarily Curculigo orchioides, Epimedium brevicornum, and MO and have been shown to significantly reduce serum lipid peroxide (LPO) contents while enhancing superoxide dismutase (SOD) and catalase (CAT) activities in aging rats, suggesting potential anti-aging effects. Enhancement of antioxidant enzyme expression can increase the activity of antioxidant enzymes and suppress the generation of free radicals (Shen et al., 1995).
Bajitianwan (BJTW) is a TCM prescription with a long history and mainly consists of MO, Acorus Tatarinowii Schott, Lycium Chinese Mill, and Poria Cocos (Schw.) Wolf. BJTW has been used to treat cognitive impairment for hundreds of years. In a D-galactose-induced male Wistar rat aging model, BJTW significantly reduced the latency at which rats could find the target platform and increased the time of swimming in the target quadrant. BJTW also has positive effects on age-related memory impairment and may be a promising antioxidant candidate for the treatment of AD (Xu et al., 2020).
Dihuang Yinzi (DY) is a tonic prescription that nourishes kidney Yin, tonifies kidney Yang, opens the orificium, and resolves phlegm. MO is one of the major components of DY. DY can significantly alleviate the impairment of learning and memory in ischemic rats by increasing the expression of extracellular signal-regulated protein kinase and enhancing synapse formation (Hu et al., 2009). In traditional medicine, aging is believed to be closely associated with kidney deficiency. Because DY promotes kidney function, it may exhibit therapeutic effects in AD, in which aging is the main etiological factor (Lee et al., 2021). Moreover, DY has been shown to improve the cognition and energy metabolism of mice by protecting against mitochondrial injury (Zhu et al., 2014).
Huanshao Dan is mainly composed of yams, Radix achyranthis bidentatae, Poria Alba, and MO and has the effect of warming the kidney and toning the spleen. In a case-control study involving 309 elderly patients, Huanshao Dan significantly improved transient memory, reduced serum LPO levels, and enhanced SOD activity, resulting in clear kidney tonifying and anti-aging effects (Du et al., 1992).
Traditional prescriptions containing MO as the main ingredient have definite antidementia effects in both animals and aging patients (Kim et al., 2008). Early in vivo and in vitro studies also revealed that MO extracts may play neuroprotective roles through anti-inflammatory and antioxidant mechanisms, alleviating cognitive impairment in rat models of aging (Xie et al., 2001). Because MO extracts or active ingredients are mainly distributed in the intestinal tract, their effects on improving microbiota metabolism may also be one approach to alleviate cognitive impairment (Xie et al., 2004; Deng et al., 2015). The anti-inflammatory and antioxidant mechanisms of the main active components of MO in AD are further discussed below.
Molecular mechanisms of action of Morinda officinalis How. in Alzheimer’s disease models
The neuroprotective effects of MO have been described in several AD and aging models, and the protective mechanisms involve mainly the anti-inflammatory and antioxidant effects of MO components (Table 1). For example, bajijiasu (BJJS), an oligosaccharide isolated from MO, tonifies the kidney and brain, resulting in significant improvement in the behaviors of rats with vascular dementia and enhancement of the long-term extension effects of synaptic transmission in isolated hippocampus slices in rats (Liang et al., 2005). BJJS also increases SOD and glutathione reductase contents and activities, decreases LPO contents, and reduces lipofuscin levels in brain tissues, thereby delaying the aging of brain tissue (Chen et al., 2014b). In APPswe/PSEN1ΔE9 (APP/PS1) double transgenic mice, Cai et al. (2017) demonstrated the BJJS inhibits neuroinflammation. They compared the levels of inflammatory factors between BJJS-treated and untreated APP/PS1 mice and found that NF-κB, IL-1β, and TNF-α expression, as well as the levels of the microglia markers Iba1 and CD40, were significantly decreased in the hippocampus and cortex of APP/PS1 mice treated with high-dose BJJS. Therefore, BJJS may improve cognitive performance in APP/PS1 mice by inhibiting the neuroinflammatory response. In addition to suppressing the neuroinflammatory response, high-dose BJJS significantly reduces Aβ1–42 and β-site app cleaving enzyme 1 levels in the hippocampus and cortex and increases the expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (Cai et al., 2017).
Table 1. Pharmacological activities of M. officinalis How. in AD treatment.
A recent study revealed that OMOs can significantly enhance learning and memory abilities and alleviate symptoms of dementia (Chen et al., 2013b). Deng et al. (2020) further explored the pharmacological effects of these oligosaccharides in a D-galactose- and Aβ 25–35-induced rat model of AD and found that OMOs exerted neuroprotective effects via antioxidant-related mechanisms in the hippocampus and cortex of AD rats. Furthermore, in a rat model of AD, OMOs were shown to alleviate oxidative damage in the brain, and oligosaccharides significantly increased in the activities of CAT, SOD, and glutathione peroxidase in the hippocampus, while decreasing the content of malondialdehyde. In addition to protecting brain tissues from oxidative damage, OMOs may protect against D-galactose- and Aβ25–35-induced AD by increasing neurotransmitter levels and relative synaptophysin expression levels in AD model rats; thus, OMOs may represent a novel strategy for alleviating symptoms of AD in the clinical setting (Deng et al., 2020).
BJJS has also been shown to protect against Aβ25–35-induced neurotoxicity in pheochromocytoma cells and rats (Chen et al., 2013a). To further explore the neuroprotective mechanisms of BJJS, Chen et al. (2014b) evaluated whether BJJS inhibited oxidative stress and neural apoptosis. In an Aβ25–35-induced model of learning and memory dysfunction in rats, BJJS administration promoted SOD production, significantly increased CAT and glutathione peroxidase levels, and inhibited malondialdehyde production. Therefore, enhancement of antioxidative activity may be the main mechanism of BJJS neuroprotection. In addition, BJJS was shown to promote energy metabolism in the brain tissue of AD model rats and increase the level of acetylcholine (ACh), suggesting another potential therapeutic mechanism for BJJS efficacy in patients with AD (Chen et al., 2014b). In the APP/PS1 mouse model, BJJS also showed potential applications in the treatment of AD. Indeed, in a study by Xu et al. (2018) BJJS was shown to exert AD therapeutic effects by altering the oxidative stress reaction. In addition, BJJS can significantly reduce the levels of lipid peroxidation and ROS in APP/PS1 mice, promotes the expression of BDNF, and inhibits the endoplasmic reticulum stress response, thus indicating the neuroprotective effects of BJJS on cognitive dysfunction in APP/PS1 mice were associated with protection against oxidative stress, apoptosis, and endoplasmic reticulum stress (Xu et al., 2018).
The role of the gut microbiota in neurodegeneration is attracting much interest (Ho and Ross, 2017), and the development of new therapeutic strategies for AD may be facilitated by studies of the pathogenic role of the gut microbiota in AD (Pistollato et al., 2016). Clinically applied sodium oligomannate capsules may show efficacy in the treatment of AD by affecting the gut microbiota (Wang T. et al., 2020). Additionally, OMOs have been reported to delay the progression of AD in APP/PS1 transgenic mice and C57BL/6J male mice by regulating the diversity of the intestinal microbiota and metabolic components (Xin et al., 2019). In previous studies, Bacteroidetes levels were decreased, whereas Firmicutes levels were increased in APP/PS1 transgenic mice (Wang et al., 2015; Dao et al., 2016), and OMOs were shown to reverse these changes. In addition, through modulation of the intestinal microbiota, OMOs may regulate protein expression and intracellular signaling pathways and significantly reduce the levels of Aβ1–42 in the brain tissues of AD mice. Moreover, OMOs affect the number of typical gastrointestinal tract microorganisms, such as Lactobacillus, Bifidobacterium, and Bacteroides, in APP/PS1 transgenic mice; alter intestinal morphology, mucin production, and intestinal permeability; and reduce bacterial imbalances (Xin et al., 2018). Fructose-oligosaccharides (FOSs) are generally considered prebiotics because they stimulate the growth of Bifidobacterium and Lactobacillus. A previous study showed that FOSs derived from MO effectively improve memory in AD model animals; however, the specific neuroprotective mechanisms remain unclear (Chen et al., 2014a). In a rat model of AD, Chen et al. (2017) studied the therapeutic effects of FOSs on AD via multiple pathways. First, FOSs were found to enhance antioxidant activity and alleviate D-galactose-induced learning and memory dysfunction in rats. Second, ACh levels were shown to be significantly increased in AD model rats treated with FOSs, and FOSs alleviated brain swelling and neuronal apoptosis and decreased the expression of intracellular markers (Tau and Aβ1–42). Third, FOSs were found to alter the diversity and stability of the microbial community, enhance the inflammatory environment, promote the secretion of certain monoamine neurotransmitters (e.g., NE, DA, and 5-HT) in a concentration-dependent manner, and alleviate the learning and memory dysfunction induced by Aβ1–42 in rats (Chen et al., 2017).
In summary, MO and its active components exert anti-AD effects mainly through antioxidant and anti-inflammatory mechanisms. Additionally, MO extract may also relieve AD symptoms through other mechanisms, including inhibition of acetylcholinesterase, butyrylcholinesterase, beta-site amyloid precursor protein cleaving enzyme 1, and advanced glycation end-products. These effects of MO extracts are exerted via anthraquinones, coumarin, and phytosterol, which have been isolated using a bioassay-guided approach; therefore, MO root extracts may have therapeutic effects as a natural medicine for treating AD (Lee et al., 2017).
Perspectives and conclusion
Despite extensive research on the pathogenesis of AD, no single theory can fully explain the pathogenesis of AD, which involves multiple inter-related molecular signaling pathways (Chakravorty et al., 2019; Agrawal and Jha, 2020). Moreover, it is difficult for single-component drugs to achieve satisfactory therapeutic effects against a certain target. As described above, various TCM prescriptions containing MO as the main ingredient have neuroprotective and antidementia properties. Studies have shown that these Chinese herbal prescriptions may show efficacy against AD by inhibiting oxidative stress, neuroinflammatory injury, apoptosis, and other biological processes (Hao et al., 2019; Li et al., 2003). Indeed, TCM prescriptions are typically advantageous because they contain multiple components and target multiple mechanisms and pathways (Shen et al., 2019; Wang K. X. et al., 2020). One of the difficulties in the study of TCM prescriptions is the complexity of the medicine. Therefore, many studies have focused on identifying and characterizing the monomers and active components of TCMs.
Among the active components of MO, BJJS and OMOs have been the most extensively studied with regard to the treatment of AD using in vivo and in vitro experiments (Figure 3). Other active components of MO, such as iridoid glycosides, have significant anti-inflammatory effects (Zhang et al., 2020), and pharmacokinetic studies have suggested that iridoid glycosides are mainly distributed in the intestinal tract, suggesting potential AD therapeutic effects via alteration of the intestinal inflammatory response (Gao et al., 2021). However, existing studies still have some limitations. First, in terms of chemical composition, extensive screening of drug components has been carried out, and targeted studies should be performed based on the pharmacological action of MO. Furthermore, studies of the pharmacological effects of MO, the modeling methods and observation indexes were relatively simple, and many experiments were reproducible. Finally, in terms of pharmacological studies, most existing studies have focused on the observation and evaluation of drug efficacy, without in-depth and systematic exploration of the mechanisms of actions.
Figure 3. Antioxidative and Anti-inflammatory activities of Morinda officinalis How. (MO) and its main components. MO may be used to treat Alzheimer’s disease and improve functional behavioral outcomes by reducing oxidative stress, inhibiting inflammatory factors, enhancing the intestinal microbiome and metabolome, and increasing neurotransmitter and neurotrophic factor expression. 5-HT, 5-hydroxytryptamine; BDNF, brain-derived neurotrophic factor; DA, dopamine; IL-1β, interleukin-1β; MDA, malondialdehyde; NE, norepinephrine; NF-κB, nuclear factor kappa-B; ROS, reactive oxygen species; TNF-α, tumor necrosis factor α.
MO has been widely used in TCM prescriptions, and the biological effects of its active components have been confirmed in many studies. The findings of these studies have suggested that MO may have multipotent neuroprotective functions elicited through its anti-inflammatory and antioxidant effects. Accordingly, MO may have applications in the treatment of aging and AD. However, the synergistic effect, safety, efficacy, bioavailability, and metabolism of the components of MO need to be further studied.
Author contributions
YZ and MZ wrote the manuscript. YZ produced the figures. MZ contributed to the editing and revision of the review. Both authors have read and approved the final manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Agrawal, I., and Jha, S. (2020). Mitochondrial dysfunction and Alzheimer’s disease: Role of microglia. Front. Aging Neurosci. 12:252. doi: 10.3389/fnagi.2020.00252
Cai, H., Wang, Y., He, J., Cai, T., Wu, J., Fang, J., et al. (2017). Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice. Oncotarget 8, 92621–92634.
Cai, M., Liu, M., Chen, P., Liu, H., Wang, Y., Yang, D., et al. (2021). Iridoids with anti-inflammatory effect from the aerial parts of Morinda officinalis How. Fitoterapia 153:104991. doi: 10.1016/j.fitote.2021.104991
Chakravorty, A., Jetto, C. T., and Manjithaya, R. (2019). Dysfunctional mitochondria and mitophagy as drivers of Alzheimer’s disease pathogenesis. Front Aging Neurosci 11:311. doi: 10.3389/fnagi.2019.00311
Chen, D., Yang, X., Yang, J., Lai, G., Yong, T., Tang, X., et al. (2017). Prebiotic effect of fructooligosaccharides from Morinda officinalis on Alzheimer’s disease in rodent models by targeting the microbiota-gut-brain axis. Front. Aging Neurosci. 9:403. doi: 10.3389/fnagi.2017.00403
Chen, D. L., Li, N., Lin, L., Long, H. M., Lin, H., Chen, J., et al. (2014a). Confocal mirco-Raman spectroscopic analysis of the antioxidant protection mechanism of the oligosaccharides extracted from Morinda officinalis on human sperm DNA. J. Ethnopharmacol. 153, 119–124. doi: 10.1016/j.jep.2014.01.021
Chen, D. L., Zhang, P., Lin, L., Zhang, H. M., Deng, S. D., Wu, Z. Q., et al. (2014b). Protective effects of bajijiasu in a rat model of Aβ25?35-induced neurotoxicity. J. Ethnopharmacol. 154, 206–217.
Chen, D. L., Zhang, P., Lin, L., Shuai, O., Zhang, H. M., Liu, S. H., et al. (2013a). Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells. Cell. Mol. Neurobiol. 33, 837–850. doi: 10.1007/s10571-013-9950-7
Chen, D. L., Zhang, P., Lin, L., Zhang, H. M., and Liu, S. H. (2013b). [Protective effect of oligosaccharides from Morinda officinalis on beta-amyloid-induced dementia rats]. Zhongguo Zhong Yao Za Zhi 38, 1306–1309.
Chen, Z., and Zhong, C. (2014). Oxidative stress in Alzheimer’s disease. Neurosci. Bull. 30, 271–281.
Chi, L., Khan, I., Lin, Z., Zhang, J., Lee, M. Y. S., Leong, W., et al. (2020). Fructo-oligosaccharides from Morinda officinalis remodeled gut microbiota and alleviated depression features in a stress rat model. Phytomedicine 67:153157. doi: 10.1016/j.phymed.2019.153157
Choi, J., Lee, K. T., Choi, M. Y., Nam, J. H., Jung, H. J., Park, S. K., et al. (2005). Antinociceptive anti-inflammatory effect of Monotropein isolated from the root of Morinda officinalis. Biol. Pharm. Bull. 28, 1915–1918. doi: 10.1248/bpb.28.1915
Cui, C., Yang, M., Yao, Z., Cao, B., Luo, Z., Xu, Y., et al. (1995). [Antidepressant active constituents in the roots of Morinda officinalis How]. Zhongguo Zhong Yao Za Zhi 20, 36–39,62–63.
Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., et al. (2016). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut 65, 426–436. doi: 10.1136/gutjnl-2014-308778
Deng, S. D., Zhang, P., Lin, L., Xiao, F. X., and Lin, J. R. (2015). [Study on intestinal absorption features of oligosaccharides in Morinda officinalis How. with sigle-pass perfusion]. Zhongguo Zhong Yao Za Zhi 40, 134–140.
Deng, S., Lu, H., Chi, H., Wang, Y., Li, X., and Ye, H. (2020). Neuroprotective effects of OMO within the hippocampus and cortex in a D-galactose and Aβ (25-35)-induced rat model of Alzheimer’s disease. Evid. Based Complement. Alternat. Med. 2020:1067541.
Du, X., Yang, R. X., and Chen, X. Q. (1992). [Effect on anti-aging and treating yang deficiency of kidney with huanshao dan capsules. A clinical report of 309 cases]. Zhongguo Zhong Xi Yi Jie He Za Zhi 12, 24–25.
Gao, C., Yu, S., Zhang, X., Dang, Y., Han, D. D., Liu, X., et al. (2021). Dual functional eudragit(§) S100/L30D-55 and PLGA colon-targeted nanoparticles of iridoid glycoside for improved treatment of induced ulcerative colitis. Int. J. Nanomedicine 16, 1405–1422. doi: 10.2147/IJN.S291090
Hao, Q., Nan, T., Zhou, L., Kang, L., Guo, L., and Yu, Y. (2019). Rapid simultaneous quantification of fructooligosaccharides in Morinda officianalis by ultra-high performance liquid chromatography. J. Sep. Sci. 42, 2222–2230. doi: 10.1002/jssc.201801287
Hao, Q., Zhou, J., Zhou, L., Kang, L., Nan, T., Yu, Y., et al. (2020). Prediction the contents of fructose, glucose, sucrose, fructo-oligosaccharides and iridoid glycosides in Morinda officinalis radix using near-infrared spectroscopy. Spectrochim. Acta A Mol. Biomol. Spectrosc. 234:118275. doi: 10.1016/j.saa.2020.118275
Hao, Y., Guo, M., Feng, Y., Dong, Q., and Cui, M. (2020). Lysophospholipids and their G-coupled protein signaling in Alzheimer’s disease: From physiological performance to pathological impairment. Front. Mol. Neurosci. 13:58. doi: 10.3389/fnmol.2020.00058
Ho, P., and Ross, D. A. (2017). More than a gut feeling: The implications of the gut microbiota in psychiatry. Biol. Psychiatry 81, e35–e37.
Hu, R., Yin, C. L., Wu, N., Cui, G. Y., Meng, H., Wu, X. G., et al. (2009). Traditional Chinese herb Dihuang Yinzi (DY) plays neuroprotective and anti-dementia role in rats of ischemic brain injury. J. Ethnopharmacol. 121, 444–450. doi: 10.1016/j.jep.2008.09.035
Hu, X., Wang, T., and Jin, F. (2016). Alzheimer’s disease and gut microbiota. Sci. China Life Sci. 59, 1006–1023.
Huang, Y. Q., Fan, Y. N., Jia, T. Z., Geng, T. T., and Shi, J. (2016). [Effect of Morinda officinalis root and its salt-processing product on energy metabolism in rats with yang deficiency]. Zhong Yao Cai 39, 1028–1031.
Jiang, K., Huang, D., Zhang, D., Wang, X., Cao, H., Zhang, Q., et al. (2018). Investigation of inulins from the roots of Morinda officinalis for potential therapeutic application as anti-osteoporosis agent. Int. J. Biol. Macromol. 120, 170–179. doi: 10.1016/j.ijbiomac.2018.08.082
Kim, S. W., Ha, N. Y., Kim, K. I., Park, J. K., and Lee, Y. H. (2008). Memory-improving effect of formulation-MSS by activation of hippocampal MAPK/ERK signaling pathway in rats. BMB Rep. 41, 242–247. doi: 10.5483/bmbrep.2008.41.3.242
Lee, J. Y., Kim, J. Y., Lee, J. Y., Jung, J. H., and Jung, I. C. (2021). Efficacy of jihwangeumja (Dihuang Yinzi) on cognitive function and activities of daily living in patients with Alzheimer disease: A protocol for a systematic review and meta-analysis. Medicine 100:e25592. doi: 10.1097/MD.0000000000025592
Lee, Y. K., Bang, H. J., Oh, J. B., and Whang, W. K. (2017). Bioassay-guided isolated compounds from Morinda officinalis inhibit Alzheimer’s disease pathologies. Molecules 22:1638. doi: 10.3390/molecules22101638
Li, Y. F., Gong, Z. H., Yang, M., Zhao, Y. M., and Luo, Z. P. (2003). Inhibition of the oligosaccharides extracted from Morinda officinalis, a Chinese traditional herbal medicine, on the corticosterone induced apoptosis in PC12 cells. Life Sci. 72, 933–942. doi: 10.1016/s0024-3205(02)02331-7
Liang, H. Y., Wu, W., and Chen, H. (2005). [Behavioral effects of bajijiasu on vascular dementia and its mechanism in rats]. Contemp. Med. Health 2, 8–10.
Liu, Z. W., Luo, Z. H., Meng, Q. Q., Zhong, P. C., Hu, Y. J., and Shen, X. L. (2020). Network pharmacology-based investigation on the mechanisms of action of Morinda officinalis How. in the treatment of osteoporosis. Comput. Biol. Med. 127:104074. doi: 10.1016/j.compbiomed.2020.104074
Luo, H., Wang, Y., Qin, Q., Wang, Y., Xu, J., and He, X. (2021). Anti-inflammatory naphthoates and anthraquinones from the roots of Morinda officinalis. Bioorg. Chem. 110:104800. doi: 10.1016/j.bioorg.2021.104800
Murata, K., Abe, Y., Futamura-Masuda, M., Uwaya, A., Isami, F., Deng, S., et al. (2014). Effect of Morinda citrifolia fruit extract and its iridoid glycosides on blood fluidity. J. Nat. Med. 68, 498–504. doi: 10.1007/s11418-014-0826-z
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., and Battino, M. (2016). Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74, 624–634.
Qiu, Z. K., Liu, C. H., Gao, Z. W., He, J. L., Liu, X., Wei, Q. L., et al. (2016). The inulin-type oligosaccharides extract from Morinda officinalis, a traditional Chinese herb, ameliorated behavioral deficits in an animal model of post-traumatic stress disorder. Metab. Brain Dis. 31, 1143–1149. doi: 10.1007/s11011-016-9853-7
Sang, S., He, K., Liu, G., Zhu, N., Cheng, X., Wang, M., et al. (2001). A new unusual iridoid with inhibition of activator protein-1 (AP-1) from the leaves of Morinda citrifolia L. Org. Lett. 3, 1307–1309. doi: 10.1021/ol0156648
Shen, H. B., Zhou, Y. N., Zheng, J., and Zhu, R. H. (2019). [”Multi-component-multi-target-multi-pathway” mechanism of Kuihua Hugan Tablets based on network pharmacology]. Zhongguo Zhong Yao Za Zhi 44, 1464–1474.
Shen, X. H., Fang, Z. Q., and Wu, D. X. (1995). [Effect of er-xian decoction and its disassembled prescription on enzyme activities and their gene expression of antioxidant enzymes in aging rat]. Zhongguo Zhong Xi Yi Jie He Za Zhi 15, 672–674.
Shin, J. S., Yun, K. J., Chung, K. S., Seo, K. H., Park, H. J., Cho, Y. W., et al. (2013). Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-κB inactivation. Food Chem. Toxicol. 53, 263–271. doi: 10.1016/j.fct.2012.12.013
Singh, B., and Sharma, R. A. (2020). Indian Morinda species: A review. Phytother. Res. 34, 924–1007.
Soon, Y. Y., and Tan, B. K. (2002). Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Med. J. 43, 077–085.
Tao, B., Gao, H., Zheng, M., Luo, Z., Liu, L., Bai, W., et al. (2016). Preclinical modeling and multimodality imaging of chronic myocardial infarction in minipigs induced by novel interventional embolization technique. EJNMMI Res. 6:59. doi: 10.1186/s13550-016-0214-7
Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., et al. (2015). Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 9, 1–15. doi: 10.1038/ismej.2014.99
Wang, K. X., Gao, Y., Lu, C., Li, Y., Zhou, B. Y., Qin, X. M., et al. (2020). Uncovering the complexity mechanism of different formulas treatment for rheumatoid arthritis based on a novel network pharmacology model. Front. Pharmacol. 11:1035. doi: 10.3389/fphar.2020.01035
Wang, T., Kuang, W., Chen, W., Xu, W., Zhang, L., Li, Y., et al. (2020). A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia. Alzheimers Res. Ther. 12:110. doi: 10.1186/s13195-020-00678-3
Wang, M. Y., West, B. J., Jensen, C. J., Nowicki, D., Su, C., Palu, A. K., et al. (2002). Morinda citrifolia (Noni): A literature review and recent advances in Noni research. Acta Pharmacol. Sin. 23, 1127–1141.
Wu, L., Xiong, X., Wu, X., Ye, Y., Jian, Z., Zhi, Z., et al. (2020). Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front. Mol. Neurosci. 13:28. doi: 10.3389/fnmol.2020.00028
Wu, Y., Girmay, S., Da Silva, V. M., Perry, B., Hu, X., and Tan, G. T. (2015). The role of endophytic fungi in the anticancer activity of Morinda citrifolia Linn. (Noni). Evid. Based Complement. Alternat. Med. 2015:393960. doi: 10.1155/2015/393960
Wu, Z. Q., Chen, D. L., Lin, F. H., Lin, L., Shuai, O., Wang, J. Y., et al. (2015). Effect of bajijiasu isolated from Morinda officinalis F. C. how on sexual function in male mice and its antioxidant protection of human sperm. J. Ethnopharmacol. 164, 283–292. doi: 10.1016/j.jep.2015.02.016
Xie, M., Yuan, X. Q., Zhang, J. J., Chen, W. W., Zhang, W., and Wang, X. (2001). The effect of anti-oxidation of Dihuang Yinzi on LPO and enzymes concerned in the blood and brain of aging rat. Chin. J. Exp. Tradit. Med. Formulae 7, 21–23.
Xie, N., Zou, C. P., Niu, Y. C., and Song, L. (2004). Effect of decoction of Rehmannia on the expression of apoptosis of hippocampal neurons model of Alzheimer’s disease. Chin. J. Exp. Tradit. Med. Formulae 10, 29–32.
Xin, Y., Diling, C., Jian, Y., Ting, L., Guoyan, H., Hualun, L., et al. (2018). Effects of oligosaccharides from Morinda officinalis on gut microbiota and metabolome of APP/PS1 transgenic mice. Front. Neurol. 9:412. doi: 10.3389/fneur.2018.00412
Xin, Y., Diling, C., Tianlu, C., Jun, Z., Xiaocui, T., Yinrui, G., et al. (2019). Oligosaccharides from Morinda officinalis slow the progress of aging mice by regulating the key microbiota-metabolite pairs. Evid. Based Complement. Alternat. Med. 2019:9306834. doi: 10.1155/2019/9306834
Xu, H., Liu, L., Chen, Y., Ma, H., Li, M., Qu, W., et al. (2019). The chemical character of polysaccharides from processed Morindae officinalis and their effects on anti-liver damage. Int. J. Biol. Macromol. 141, 410–421. doi: 10.1016/j.ijbiomac.2019.08.213
Xu, L. Z., Xu, D. F., Han, Y., Liu, L. J., Sun, C. Y., Deng, J. H., et al. (2017). BDNF-GSK-3β-β-catenin pathway in the mPFC is involved in antidepressant-like effects of Morinda officinalis oligosaccharides in rats. Int. J. Neuropsychopharmacol. 20, 83–93. doi: 10.1093/ijnp/pyw088
Xu, T. T., Zhang, Y., He, J. Y., Luo, D., Luo, Y., Wang, Y. J., et al. (2018). Bajijiasu ameliorates β-amyloid-triggered endoplasmic reticulum stress and related pathologies in an Alzheimer’s disease model. Cell. Physiol. Biochem. 46, 107–117. doi: 10.1159/000488414
Xu, W., Liu, X., He, X., Jiang, Y., Zhang, J., Zhang, Q., et al. (2020). Bajitianwan attenuates D-galactose-induced memory impairment and bone loss through suppression of oxidative stress in aging rat model. J. Ethnopharmacol. 261:112992. doi: 10.1016/j.jep.2020.112992
Yao, H., Wu, H., Feng, C. H., Zhao, S., and Liang, S. J. (2004). [Relation between root structure and accumulation of anthraquinones of Morinda officinalis]. Shi Yan Sheng Wu Xue Bao 37, 96–102.
Yoshikawa, M., Yamaguchi, S., Nishisaka, H., Yamahara, J., and Murakami, N. (1995). Chemical constituents of Chinese natural medicine, morindae radix, the dried roots of Morinda officinalis how.: Structures of morindolide and morofficinaloside. Chem. Pharm. Bull. 43, 1462–1465. doi: 10.1248/cpb.43.1462
Zhang, D., Fan, L., Yang, N., Li, Z., Sun, Z., Jiang, S., et al. (2022). Discovering the main “reinforce kidney to strengthening Yang” active components of salt Morinda officinalis based on the spectrum-effect relationship combined with chemometric methods. J. Pharm. Biomed. Anal. 207:114422. doi: 10.1016/j.jpba.2021.114422
Zhang, H., Li, J., Xia, J., and Lin, S. (2013). Antioxidant activity and physicochemical properties of an acidic polysaccharide from Morinda officinalis. Int. J. Biol. Macromol. 58, 7–12. doi: 10.1016/j.ijbiomac.2013.03.031
Zhang, H. L., Li, J., Li, G., Wang, D. M., Zhu, L. P., and Yang, D. P. (2009). Structural characterization and anti-fatigue activity of polysaccharides from the roots of Morinda officinalis. Int. J. Biol. Macromol. 44, 257–261. doi: 10.1016/j.ijbiomac.2008.12.010
Zhang, J. H., Xin, H. L., Xu, Y. M., Shen, Y., He, Y. Q., Hsien, Y., et al. (2018). Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol. 213, 230–255. doi: 10.1016/j.jep.2017.10.028
Zhang, Q., Zhang, J. H., He, Y. Q., Zhang, Q. L., Zhu, B., Shen, Y., et al. (2020). Iridoid glycosides from Morinda officinalis How. exert anti-inflammatory and anti-arthritic effects through inactivating MAPK and NF-κB signaling pathways. BMC Complement. Med. Ther. 20:172. doi: 10.1186/s12906-020-02895-7
Zhang, W. M., Wang, W., Zhang, J. J., Wang, Z. R., Wang, Y., Hao, W. J., et al. (2016). Antibacterial constituents of hainan Morinda citrifolia (Noni) Leaves. J. Food Sci. 81, M1192–M1196. doi: 10.1111/1750-3841.13302
Zhao, W., Lu, W., Li, Z., Zhou, C. E., Fan, H., Yang, Z., et al. (2022). TCM herbal prescription recommendation model based on multi-graph convolutional network. J. Ethnopharmacol. 297:115109. doi: 10.1016/j.jep.2022.115109
Zhu, H., Lu, S., Su, W., Gong, S., Zhang, Z., and Li, P. (2014). Effect of liandouqingmai recipe on quality of life and inflammatory reactions of patients with coronary heart disease. J. Tradit. Chin. Med. 34, 539–543. doi: 10.1016/s0254-6272(15)30059-5
Zhu, J., Peng, Q., Xu, Y., Xu, H., Wan, Y., Li, Z., et al. (2020). Morinda officinalis oligosaccharides ameliorate depressive-like behaviors in poststroke rats through upregulating GLUT3 to improve synaptic activity. FASEB J. 34, 13376–13395. doi: 10.1096/fj.201902546RR
Keywords: Morinda officinalis How., neuroprotection, neuroinflammation, antioxidative, Alzheimer’s disease
Citation: Zhang Y and Zhang M (2022) Neuroprotective effects of Morinda officinalis How.: Anti-inflammatory and antioxidant roles in Alzheimer’s disease. Front. Aging Neurosci. 14:963041. doi: 10.3389/fnagi.2022.963041
Received: 07 June 2022; Accepted: 18 August 2022;
Published: 08 September 2022.
Edited by:
Gianluigi Forloni, Department of Neuroscience, Mario Negri Pharmacological Research Institute (IRCCS), ItalyReviewed by:
Pamela Maher, Salk Institute for Biological Studies, United StatesCopyright © 2022 Zhang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Meng Zhang, zhangm0810@163.com